Markus Axelsson

Markus Axelsson

UNVERIFIED PROFILE

Are you Markus Axelsson?   Register this Author

Register author
Markus Axelsson

Markus Axelsson

Publications by authors named "Markus Axelsson"

Are you Markus Axelsson?   Register this Author

28Publications

350Reads

49Profile Views

Cerebrospinal fluid biomarkers in patients with neurological symptoms but without neurological diseases.

Acta Neurol Scand 2019 Sep 31;140(3):177-183. Epub 2019 May 31.

Department of Neurology, Sahlgrenska University Hospital, Gothenburg, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ane.13118DOI Listing
September 2019

Cerebrospinal fluid neurofilament light and tau protein as mortality biomarkers in parkinsonism.

Acta Neurol Scand 2019 Aug 20;140(2):147-156. Epub 2019 May 20.

Department of Neurology, Institute of Neuroscience and Physiology at Sahlgrenska Academy, Sahlgrenska University Hospital, University of Gothenburg, Gothenburg, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ane.13116DOI Listing
August 2019

A SCA7 premutation may be a novel Mendelian modifier of MS course: A case report.

Mult Scler Relat Disord 2019 Jun 13;31:148-150. Epub 2019 Apr 13.

Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S22110348193016
Publisher Site
http://dx.doi.org/10.1016/j.msard.2019.04.009DOI Listing
June 2019

Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis.

JAMA Neurol 2019 Jun 17. Epub 2019 Jun 17.

UCL Institute of Neurology, Queen Square, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaneurol.2019.1534DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6580449PMC
June 2019

Cerebrospinal fluid NCAM levels are modulated by disease-modifying therapies.

Acta Neurol Scand 2019 May 5;139(5):422-427. Epub 2019 Mar 5.

Department of Neuroscience and Trauma, Blizard Institute, Queen Mary University of London, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ane.13069DOI Listing
May 2019

Leukoencephalopathia, demyelinating peripheral neuropathy and dural ectasia explained by a not formerly described de novo mutation in the SAMD9L gene, ends 27 years of investigations - a case report.

BMC Neurol 2019 May 3;19(1):89. Epub 2019 May 3.

Department of Clinical Neuroscience and Rehabilitation, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

View Article

Download full-text PDF

Source
https://bmcneurol.biomedcentral.com/articles/10.1186/s12883-
Publisher Site
http://dx.doi.org/10.1186/s12883-019-1319-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6499956PMC
May 2019

Sulfatide isoform pattern in cerebrospinal fluid discriminates progressive MS from relapsing-remitting MS.

J Neurochem 2018 08 3;146(3):322-332. Epub 2018 Jul 3.

Department of Clinical Chemistry and Transfusion Medicine, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jnc.14452DOI Listing
August 2018

Searching for neurodegeneration in multiple sclerosis at clinical onset: Diagnostic value of biomarkers.

PLoS One 2018 3;13(4):e0194828. Epub 2018 Apr 3.

Institute of Neuroscience and Physiology, Department of Clinical Neuroscience, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0194828PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5882126PMC
July 2018

Monitoring disease activity in multiple sclerosis using serum neurofilament light protein.

Neurology 2017 Nov 27;89(22):2230-2237. Epub 2017 Oct 27.

From the Department of Clinical Neuroscience (L.N., M.A., C.M., J.L.) and Department of Psychiatry and Neurochemistry (H.Z., K.B.), Institute of Neuroscience and Physiology at Sahlgrenska Academy, University of Gothenburg; Clinical Neurochemistry Laboratory (H.Z., K.B.), Sahlgrenska University Hospital, Mölndal, Sweden; Department of Molecular Neuroscience (H.Z.), UCL Institute of Neurology, London, UK; Department of Pharmacology and Clinical Neuroscience (P.S.), Umeå University; University Department of Clinical Neuroscience (M.K., T.O., F.P.), Neuroimmunology Unit, and Department of Clinical Sciences (A.S.), Danderyd Hospital, Karolinska Institutet, Stockholm; and Department of Neurology (M.G.), Faculty of Medicine and Health, Örebro University, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000004683DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5705244PMC
November 2017

Cerebrospinal fluid markers of neuronal and glial cell damage in patients with autoimmune neurologic syndromes with and without underlying malignancies.

J Neuroimmunol 2017 05 1;306:25-30. Epub 2017 Mar 1.

Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, Sahlgrenska Academy, University of Gothenburg, Mölndal, Sweden; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jneuroim.2017.02.018DOI Listing
May 2017

Cerebrospinal fluid biomarkers as a measure of disease activity and treatment efficacy in relapsing-remitting multiple sclerosis.

J Neurochem 2017 04 29;141(2):296-304. Epub 2016 Nov 29.

Department of Clinical Neuroscience, Institute of Neuroscience and Physiology at Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jnc.13881DOI Listing
April 2017

High Interferon-γ Uniquely in Vδ1 T Cells Correlates with Markers of Inflammation and Axonal Damage in Early Multiple Sclerosis.

Front Immunol 2017 9;8:260. Epub 2017 Mar 9.

Department of Microbiology and Immunology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg , Gothenburg , Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fimmu.2017.00260DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5343019PMC
March 2017

Cerebrospinal fluid biomarkers of inflammation and degeneration as measures of fingolimod efficacy in multiple sclerosis.

Mult Scler 2017 01 11;23(1):62-71. Epub 2016 Jul 11.

Department of Clinical Neuroscience and Rehabilitation, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1352458516639384DOI Listing
January 2017

Rituximab in multiple sclerosis: A retrospective observational study on safety and efficacy.

Neurology 2016 Nov 19;87(20):2074-2081. Epub 2016 Oct 19.

From the Department of Pharmacology and Clinical Neuroscience (J.S., R.S., P.I.-J., M.V., P.S., A.S.), Umeå University; Departments of Clinical Neuroscience (R.S., P.A., A.B., K.F., F.P.) and Clinical Sciences, Danderyd Hospital (A.S.), Karolinska Institutet, Stockholm; and Department of Clinical Neuroscience (L.N., C.M., M.A., J.L.), Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000003331DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5109942PMC
November 2016

Soluble TREM-2 in cerebrospinal fluid from patients with multiple sclerosis treated with natalizumab or mitoxantrone.

Mult Scler 2016 10 11;22(12):1587-1595. Epub 2016 Jan 11.

Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden/UCL Institute of Neurology, University College London (UCL), London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1352458515624558DOI Listing
October 2016

Rituximab versus fingolimod after natalizumab in multiple sclerosis patients.

Ann Neurol 2016 Jun 20;79(6):950-8. Epub 2016 Apr 20.

Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ana.24651DOI Listing
June 2016

YKL-40 is a CSF biomarker of intrathecal inflammation in secondary progressive multiple sclerosis.

J Neuroimmunol 2016 Mar 22;292:52-7. Epub 2016 Jan 22.

Department of Clinical Neuroscience and Physiology, University of Gothenburg, Gothenburg, Sweden. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jneuroim.2016.01.013DOI Listing
March 2016

Reduced cerebrospinal fluid concentrations of oxysterols in response to natalizumab treatment of relapsing remitting multiple sclerosis.

J Neurol Sci 2015 Nov 29;358(1-2):201-6. Epub 2015 Aug 29.

Department of Clinical Neuroscience and Rehabilitation, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jns.2015.08.1537DOI Listing
November 2015

CSF levels of YKL-40 are increased in MS and replaces with immunosuppressive treatment.

J Neuroimmunol 2014 Apr 13;269(1-2):87-9. Epub 2014 Feb 13.

Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy, University of Gothenburg, Mölndal, Sweden. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jneuroim.2014.02.004DOI Listing
April 2014

Immunosuppressive therapy reduces axonal damage in progressive multiple sclerosis.

Mult Scler 2014 Jan 23;20(1):43-50. Epub 2013 May 23.

Department of Clinical Neuroscience and Rehabilitation, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1352458513490544DOI Listing
January 2014

The influence of disease duration, clinical course, and immunosuppressive therapy on the synthesis of intrathecal oligoclonal IgG bands in multiple sclerosis.

J Neuroimmunol 2013 Nov 18;264(1-2):100-5. Epub 2013 Sep 18.

Department of Clinical Neuroscience and Rehabilitation, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jneuroim.2013.09.003DOI Listing
November 2013

MicroRNA regulate immune pathways in T-cells in multiple sclerosis (MS).

BMC Immunol 2013 Jul 29;14:32. Epub 2013 Jul 29.

Department of Molecular and Clinical Medicine, The Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2172-14-32DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3734042PMC
July 2013

Serum levels of LIGHT in MS.

Mult Scler 2013 Jun 4;19(7):871-6. Epub 2012 Oct 4.

Department of Neurology, Sahlgrenska Academy at University of Gothenburg, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1352458512463766DOI Listing
June 2013

MS risk genes are transcriptionally regulated in CSF leukocytes at relapse.

Mult Scler 2013 Apr 20;19(4):403-10. Epub 2012 Aug 20.

Department of Internal Medicine, University of Gothenburg, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1352458512455466DOI Listing
April 2013

Cerebrospinal fluid biomarkers of β-amyloid metabolism in multiple sclerosis.

Mult Scler 2013 Apr 15;19(5):543-52. Epub 2012 Oct 15.

Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1352458512460603DOI Listing
April 2013

Neurological picture: Cranial neuropathy in the blue rubber bleb nevus syndrome.

J Neurol Neurosurg Psychiatry 2010 Nov 27;81(11):1207-8. Epub 2010 Jun 27.

Department of Neurology, Rigshospitalet, DK-2100 Copenhagen, Denmark.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/jnnp.2009.194449DOI Listing
November 2010